K. Börner

2.7k total citations
89 papers, 2.1k citations indexed

About

K. Börner is a scholar working on Pharmacology, Epidemiology and Oncology. According to data from OpenAlex, K. Börner has authored 89 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmacology, 21 papers in Epidemiology and 17 papers in Oncology. Recurrent topics in K. Börner's work include Antibiotics Pharmacokinetics and Efficacy (44 papers), Drug Transport and Resistance Mechanisms (16 papers) and Antibiotic Resistance in Bacteria (16 papers). K. Börner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (44 papers), Drug Transport and Resistance Mechanisms (16 papers) and Antibiotic Resistance in Bacteria (16 papers). K. Börner collaborates with scholars based in Germany, United States and Austria. K. Börner's co-authors include P. Koeppe, H. Lode, G. Höffken, H. Lode, T. Schaberg, P. Olschewski, E. A. Rössler, Matthias Taupitz, Hans‐Martin Vieth and Michael D. Schulz and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

K. Börner

88 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Börner Germany 24 1.2k 614 561 267 256 89 2.1k
F. Sörgel Germany 29 1.3k 1.0× 646 1.1× 571 1.0× 303 1.1× 384 1.5× 99 2.6k
Deborah M. Campoli-Richards United States 20 794 0.6× 655 1.1× 363 0.6× 492 1.8× 208 0.8× 22 2.7k
P. Koeppe Germany 29 1.8k 1.5× 855 1.4× 824 1.5× 360 1.3× 381 1.5× 151 3.1k
I. Nilsson-Ehle Sweden 24 865 0.7× 357 0.6× 318 0.6× 195 0.7× 139 0.5× 58 1.8k
H. Mattie Netherlands 24 1.2k 0.9× 633 1.0× 596 1.1× 207 0.8× 242 0.9× 108 2.2k
Olivier Petitjean France 22 667 0.5× 450 0.7× 330 0.6× 225 0.8× 137 0.5× 89 1.6k
Marie‐Claude Saux France 28 1.2k 1.0× 681 1.1× 537 1.0× 242 0.9× 121 0.5× 73 2.2k
William L. Hewitt United States 23 1.1k 0.9× 516 0.8× 622 1.1× 186 0.7× 244 1.0× 66 1.9k
F. Jehl France 33 994 0.8× 697 1.1× 529 0.9× 716 2.7× 446 1.7× 176 3.2k
Marc Lebel Canada 34 886 0.7× 1.6k 2.6× 353 0.6× 319 1.2× 186 0.7× 124 3.6k

Countries citing papers authored by K. Börner

Since Specialization
Citations

This map shows the geographic impact of K. Börner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Börner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Börner more than expected).

Fields of papers citing papers by K. Börner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Börner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Börner. The network helps show where K. Börner may publish in the future.

Co-authorship network of co-authors of K. Börner

This figure shows the co-authorship network connecting the top 25 collaborators of K. Börner. A scholar is included among the top collaborators of K. Börner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Börner. K. Börner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Chan‐Young, Elisabeth Engelmann, K. Börner, & G. Offermann. (2001). Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation. Transplantation Proceedings. 33(7-8). 3621–3623. 30 indexed citations
2.
Börner, K., et al.. (2000). Metabolism of Ifosfamide to Chloroacetaldehyde Contributes to Antitumor Activity In Vivo. Drug Metabolism and Disposition. 28(5). 573–576. 29 indexed citations
3.
Schuler, Patrick J., et al.. (1997). Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes. European Respiratory Journal. 10(5). 1130–1136. 43 indexed citations
4.
Trautmann, Matthias, Markus Ruhnke, K. Börner, J. Wagner, & P. Koeppe. (1996). Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci. Antimicrobial Agents and Chemotherapy. 40(3). 776–779. 15 indexed citations
5.
Hamacher, Jürg, J Eller, K. Börner, et al.. (1996). Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. Antimicrobial Agents and Chemotherapy. 40(1). 105–109. 61 indexed citations
6.
Lode, H., et al.. (1994). Comparative Pharmacokinetics of the New Oral Cephalosporins. Drugs. 47(Supplement 3). 10–20. 11 indexed citations
7.
Müller, Hj., et al.. (1993). Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime. Antimicrobial Agents and Chemotherapy. 37(9). 1835–1841. 15 indexed citations
8.
Lode, H., et al.. (1993). Pharmacokinetics of New Oral Cephalosporins, Including a New Carbacephem. Clinical Infectious Diseases. 16(5). 646–653. 29 indexed citations
9.
Kampf, D., et al.. (1992). Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients. European Journal of Clinical Pharmacology. 42(1). 95–99. 7 indexed citations
10.
Kunkel, G., et al.. (1990). Efficacy of sustained release theophylline given at three different evening intake times in addition to a baseline medication. European Respiratory Journal. 3(2). 176–181. 3 indexed citations
11.
Meissner, Alexander, K. Börner, & P. Koeppe. (1990). Concentrations of ofloxacin in human bone and in cartilage. Journal of Antimicrobial Chemotherapy. 26(suppl D). 69–74. 30 indexed citations
12.
Lode, H., G. Höffken, K. Börner, & P. Koeppe. (1989). Unique Aspects of Quinolone Pharmacokinetics. Clinical Pharmacokinetics. 16(Supplement 1). 1–4. 12 indexed citations
13.
Kemmerich, B., K. Börner, & James E. Pennington. (1987). Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia. Antimicrobial Agents and Chemotherapy. 31(3). 417–420. 10 indexed citations
14.
Kunkel, G., V W Steinijans, & K. Börner. (1987). Chrono-Optimization of the Time of Evening Administration with Unequally Divided Twice-Daily Theophylline. Chronobiology International. 4(3). 359–368. 4 indexed citations
15.
Collmann, H., et al.. (1983). Cefotaxime Levels in Ventricular Cerebrospinal Fluid, Determined by Bioassay and by High-Performance Liquid Chromatography. Chemotherapy. 29(4). 237–243. 9 indexed citations
16.
Kemmerich, B., et al.. (1983). Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora. Antimicrobial Agents and Chemotherapy. 24(3). 333–338. 42 indexed citations
17.
Lode, H., et al.. (1983). Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administration. Journal of Antimicrobial Chemotherapy. 11(suppl B). 121–126. 1 indexed citations
18.
Rietbrock, N., et al.. (1979). The influence of intravenous canrenoate on the determination of digoxin in serum by radio- and enzyme-immunoassay.. PubMed. 17(2). 61–3. 6 indexed citations
19.
Börner, K. & N. Rietbrock. (1978). Bestimmung von Digoxin im Serum Vergleich von Radioimmunassay und heterogenem Enzymimmunassay. Clinical Chemistry and Laboratory Medicine (CCLM). 16(6). 335–42. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Sörgel Breakdown of academic impact, for papers by Deborah M. Campoli-Richards Breakdown of academic impact, for papers by P. Koeppe Breakdown of academic impact, for papers by I. Nilsson-Ehle Breakdown of academic impact, for papers by H. Mattie Breakdown of academic impact, for papers by Olivier Petitjean Breakdown of academic impact, for papers by Marie‐Claude Saux Breakdown of academic impact, for papers by William L. Hewitt Breakdown of academic impact, for papers by F. Jehl Breakdown of academic impact, for papers by Marc Lebel
Rankless by CCL
2026